Trade margin rationalisation for 137 anti-cancer drugs; revised prices to take effect from November 9
The National Pharmaceutical Pricing Authority (NPPA), under the Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, has undertaken Trade Margin Rationalisation (TMR) for 137 identified non-scheduled anti-cancer drugs in the public interest.
Read the full report on The Statesman
Story file
- Section
- Health
- Topics
- Health alerts
- First reported by
- The Statesman
- Reporter
- statesman news service
- Published
- Saturday, 17 October 2026, 10:03 pm IST
- Coverage
- One outlet so far
How this page works. The Headline Update lists this report from The Statesman with a short summary and a link to the original. The original reporting and photograph belong to the publisher. Spotted an error in our summary? Tell our corrections desk.
